Related Experiment Video
Updated: May 7, 2026

Functional Characterization of Regulatory Macrophages That Inhibit Graft-reactive Immunity
Published on: June 7, 2017
A single glutamic acid residue plays a key role in the transcriptional activation function of lambda repressor
F D Bushman1, C Shang, M Ptashne
1Laboratory of Molecular Biology, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, Maryland 20892.
Abstract:
Previous experiments have suggested that negative charge is an important aspect of the activating region of lambda repressor as it is for at least one class of eukaryotic transcriptional activators. Here we randomize amino acids in the activating region of repressor and assay the function of over 100 variants. We find that acidic residues at the four solvent-exposed positions on the surface of an alpha helix (helix 2 in the structure) together comprise a strong activating region. Only one of these acidic residues, however, is critical for activation, and at this position glutamate is strongly preferred to aspartate. At the three remaining positions, certain uncharged residues (different ones at each position) function as well as or better than the acidic residues. Basic residues, however, are highly detrimental to function at all four positions. Our mutagenesis studies also suggest limitations on amino acid substitutions that allow formation of the helix-turn-helix DNA binding motif found in repressor and in many other DNA binding regulatory proteins.
Related Concept Videos
07:29Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies
04:04Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
09:45Radiosensitivity of Cancer Stem Cells in Lung Cancer Cell Lines
07:17An Orthotopic Resectional Mouse Model of Pancreatic Cancer
06:40An In Vivo Mouse Model of Total Intravenous Anesthesia During Cancer Resection Surgery
05:17Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing

